COMMUNIQUÉS West-GlobeNewswire

H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors
30/07/2019
TAMPA, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung Health Institute , today [...]
Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, August 6th
30/07/2019
CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic [...]
Covetrus Announces Second Quarter 2019 Earnings Release Date and Conference Call Information
30/07/2019
PORTLAND, Maine, July 30, 2019 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2019 results the morning of [...]
Beyond Air™ Schedules First Fiscal Quarter 2020 Financial Results Conference Call and Webcast
30/07/2019
Call scheduled for Wednesday, August 14th at 4:30pm Eastern Time GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and [...]
Predictive Oncology Subsidiary Helomics Executes Next Phase of Agreement with Interpace to Enhance the Diagnosis of Thyroid Cancer via AI-Driven Models
30/07/2019
Three Most Recent Pittsburgh-Based Development Partnerships Demonstrate Value and Recognition for Helomics’ AI-Driven, Patient Derived “Multi-Omic” Discovery Platform MINNEAPOLIS, July 30, 2019 (GLOBE NEWSWIRE) -- [...]
Capricor Therapeutics to Present Second Quarter 2019 Financial Results and Recent Corporate Update on August 6
30/07/2019
LOS ANGELES, July 30, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]
Maverick Technology Solutions Proudly Announces The Issuance Of US Patent No. D854,064 S
30/07/2019
Industry Leading Extraction Press Manufacturer of the acclaimed Rosinbomb Product Line Continues Course of Innovation Over Imitation RENO, Nev., July 30, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK [...]
Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income
30/07/2019
LAKEWOOD, Colo., July 30, 2019 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and adjusted operating income 1 (“AOI”) for [...]
Establishment Labs to Announce Second Quarter 2019 Financial Results on August 13, 2019
30/07/2019
NEW YORK, July 30, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Cerner Leads New Era of Health Care Innovation
30/07/2019
Cerner and Amazon to Work on Future Collaboration Names AWS as its Preferred Cloud Provider to Double-Down on Focus to Disrupt Health Care KANSAS CITY, Mo., July 30, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ: [...]
NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board
30/07/2019
Experts from Harvard and National Cancer Institute to aid in development of novel antisense oligonucleotide therapies for genome-wide transcriptional regulation PITTSBURGH, July 30, 2019 (GLOBE NEWSWIRE) -- NeuBase [...]
Foamix Announces $64 Million Capital Financing Investment by Perceptive Advisors and OrbiMed
30/07/2019
Foamix secures up to $50 million in non-dilutive funding Company secures $14 million via a registered direct offering of equity REHOVOT, Israel and BRIDGEWATER, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Foamix [...]
Zogenix to Release Second Quarter 2019 Financial Results and Host Conference Call and Webcast on August 6
30/07/2019
EMERYVILLE, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]
BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
30/07/2019
RALEIGH, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced its [...]
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference
30/07/2019
SAN DIEGO and TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Meridian Bioscience Reports Third Quarter 2019 Operating Results
30/07/2019
CINCINNATI, Ohio, July 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter and first nine months ended June 30, 2019. Third Quarter 2019 [...]
Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2019 Operational and Financial Results on August 13, 2019
30/07/2019
BEDMINSTER, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live [...]
Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis
30/07/2019
— Diroximel Fumarate Demonstrated Statistically Superior Gastrointestinal (GI) Tolerability on EVOLVE-MS-2 Study’s Primary Endpoint Assessing Self-Reported GI Events — — Discontinuations Due to GI Events were Less than [...]
T2 Biosystems to Present at the Canaccord Genuity Growth Conference
30/07/2019
LEXINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs [...]

Pages